Literature DB >> 33546773

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy.

Mayarling Francisca Troncoso1, Mario Pavez1, Carlos Wilson1, Daniel Lagos1, Javier Duran1, Sebastián Ramos1, Genaro Barrientos1, Patricio Silva2, Paola Llanos3, Carla Basualto-Alarcón4,5, B Daan Westenbrink6, Sergio Lavandero7,8, Manuel Estrada9.   

Abstract

BACKGROUND: Testosterone regulates nutrient and energy balance to maintain protein synthesis and metabolism in cardiomyocytes, but supraphysiological concentrations induce cardiac hypertrophy. Previously, we determined that testosterone increased glucose uptake-via AMP-activated protein kinase (AMPK)-after acute treatment in cardiomyocytes. However, whether elevated glucose uptake is involved in long-term changes of glucose metabolism or is required during cardiomyocyte growth remained unknown. In this study, we hypothesized that glucose uptake and glycolysis increase in testosterone-treated cardiomyocytes through AMPK and androgen receptor (AR).
METHODS: Cultured cardiomyocytes were stimulated with 100 nM testosterone for 24 h, and hypertrophy was verified by increased cell size and mRNA levels of β-myosin heavy chain (β-mhc). Glucose uptake was assessed by 2-NBDG. Glycolysis and glycolytic capacity were determined by measuring extracellular acidification rate (ECAR).
RESULTS: Testosterone induced cardiomyocyte hypertrophy that was accompanied by increased glucose uptake, glycolysis enhancement and upregulated mRNA expression of hexokinase 2. In addition, testosterone increased AMPK phosphorylation (Thr172), while inhibition of both AMPK and AR blocked glycolysis and cardiomyocyte hypertrophy induced by testosterone. Moreover, testosterone supplementation in adult male rats by 5 weeks induced cardiac hypertrophy and upregulated β-mhc, Hk2 and Pfk2 mRNA levels.
CONCLUSION: These results indicate that testosterone stimulates glucose metabolism by activation of AMPK and AR signaling which are critical to induce cardiomyocyte hypertrophy.

Entities:  

Keywords:  AMP-activated protein kinase; Androgen receptor; Cardiac hypertrophy; Glucose transport; Glycolysis; Testosterone

Mesh:

Substances:

Year:  2021        PMID: 33546773      PMCID: PMC7863443          DOI: 10.1186/s40659-021-00328-4

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  79 in total

Review 1.  Androgen Receptor Structure, Function and Biology: From Bench to Bedside.

Authors:  Rachel A Davey; Mathis Grossmann
Journal:  Clin Biochem Rev       Date:  2016-02

Review 2.  Metabolism in cardiomyopathy: every substrate matters.

Authors:  Julia Ritterhoff; Rong Tian
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

Review 3.  Anabolic androgenic steroids and intracellular calcium signaling: a mini review on mechanisms and physiological implications.

Authors:  J M Vicencio; M Estrada; D Galvis; R Bravo; A E Contreras; D Rotter; G Szabadkai; J A Hill; B A Rothermel; E Jaimovich; S Lavandero
Journal:  Mini Rev Med Chem       Date:  2011-05       Impact factor: 3.862

4.  Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy.

Authors:  Robert W Myers; Hong-Ping Guan; Juliann Ehrhart; Aleksandr Petrov; Srinivasa Prahalada; Effie Tozzo; Xiaodong Yang; Marc M Kurtz; Maria Trujillo; Dinko Gonzalez Trotter; Danqing Feng; Shiyao Xu; George Eiermann; Marie A Holahan; Daniel Rubins; Stacey Conarello; Xiaoda Niu; Sandra C Souza; Corin Miller; Jinqi Liu; Ku Lu; Wen Feng; Ying Li; Ronald E Painter; James A Milligan; Huaibing He; Franklin Liu; Aimie Ogawa; Douglas Wisniewski; Rory J Rohm; Liyang Wang; Michelle Bunzel; Ying Qian; Wei Zhu; Hongwu Wang; Bindu Bennet; Lisa LaFranco Scheuch; Guillermo E Fernandez; Cai Li; Michael Klimas; Gaochao Zhou; Margaret van Heek; Tesfaye Biftu; Ann Weber; David E Kelley; Nancy Thornberry; Mark D Erion; Daniel M Kemp; Iyassu K Sebhat
Journal:  Science       Date:  2017-07-13       Impact factor: 47.728

5.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.

Authors:  A S Marsin; L Bertrand; M H Rider; J Deprez; C Beauloye; M F Vincent; G Van den Berghe; D Carling; L Hue
Journal:  Curr Biol       Date:  2000-10-19       Impact factor: 10.834

Review 6.  Glucose metabolism and cardiac hypertrophy.

Authors:  Stephen C Kolwicz; Rong Tian
Journal:  Cardiovasc Res       Date:  2011-05-01       Impact factor: 10.787

7.  The Association between Androgenic Hormone Levels and the Risk of Developing Coronary Artery Disease (CAD).

Authors:  Farzad Allameh; Gholamreza Pourmand; Ali Bozorgi; Sepideh Nekuie; Farshad Namdari
Journal:  Iran J Public Health       Date:  2016-01       Impact factor: 1.429

8.  Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy.

Authors:  Javier Duran; Daniel Lagos; Mario Pavez; Mayarling F Troncoso; Sebastián Ramos; Genaro Barrientos; Cristian Ibarra; Sergio Lavandero; Manuel Estrada
Journal:  Front Pharmacol       Date:  2017-09-11       Impact factor: 5.810

9.  Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.

Authors:  Simon A Hawley; Jérôme Boudeau; Jennifer L Reid; Kirsty J Mustard; Lina Udd; Tomi P Mäkelä; Dario R Alessi; D Grahame Hardie
Journal:  J Biol       Date:  2003-09-24

10.  Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.

Authors:  J B Tennakoon; Y Shi; J J Han; E Tsouko; M A White; A R Burns; A Zhang; X Xia; O R Ilkayeva; L Xin; M M Ittmann; F G Rick; A V Schally; D E Frigo
Journal:  Oncogene       Date:  2013-11-04       Impact factor: 9.867

View more
  6 in total

1.  Nandrolone Supplementation Promotes AMPK Activation and Divergent 18[FDG] PET Brain Connectivity in Adult and Aged Mice.

Authors:  N R Strogulski; A Kopczynski; V G de Oliveira; R B Carteri; G Hansel; G T Venturin; S Greggio; J C DaCosta; M A De Bastiani; M S Rodolphi; L V Portela
Journal:  Neurochem Res       Date:  2022-04-12       Impact factor: 3.996

Review 2.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

3.  Quercetin Attenuates Osteoporosis in Orchiectomy Mice by Regulating Glucose and Lipid Metabolism via the GPRC6A/AMPK/mTOR Signaling Pathway.

Authors:  Jie Sun; Yalan Pan; Xiaofeng Li; Lining Wang; Mengmin Liu; Pengcheng Tu; Chengjie Wu; Jirimutu Xiao; Qiuge Han; Weiwei Da; Yong Ma; Yang Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

4.  Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease.

Authors:  Yufeng Mei; Yongnan Lyu; Zhiming Zhao; Yan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

5.  Testosterone ameliorates age-related brain mitochondrial dysfunction.

Authors:  Wensheng Yan; Tianyun Zhang; Yunxiao Kang; Guoliang Zhang; Xiaoming Ji; Xu Feng; Geming Shi
Journal:  Aging (Albany NY)       Date:  2021-06-17       Impact factor: 5.682

6.  mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats.

Authors:  Jianshu Chen; Jing Yu; Ruowen Yuan; Ningyin Li; Caie Li; Xiaofang Zhang
Journal:  J Endocrinol       Date:  2022-01-31       Impact factor: 4.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.